Skip to content

Study note

Effect of photobiomodulation therapy on performance and running economy in runners: A randomized double-blinded placebo-controlled trial.

PMID 33459175 (2021): photobiomodulation, therapy — Running economy (study note for endurance athletes).

Updated Jul 22, 2026

Read the study note

Study note • PMID 33459175

Effect of photobiomodulation therapy on performance and running economy in runners: A randomized double-blinded placebo-controlled trial.

Journal of sports sciences2021 • DOI 10.1080/02640414.2021.1872930

How to use this page

This note summarizes one study record. Check the participants, methods, results, and limitations before applying it to training.

  • Design signal: randomized trial.
  • Population relevance: athlete/trained context.
  • Consistency: single-study evidence.
  • Practical recommendation depends on tolerance, context, and whether it protects training consistency.

ELI5

In plain language

The objective of this study was to evaluate effects of photobiomodulation therapy (PBMT) on the 3000 m running performance (primary outcome), running economy (RE), metabolic cost and ratings of… (randomized trial; athletes).

The abstract doesn’t indicate a clear change in Running economy under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: The objective of this study was to evaluate effects of photobiomodulation therapy (PBMT) on the 3000 m running performance (primary outcome), running economy (RE), metabolic cost and ratings of…
  • The abstract doesn’t indicate a clear change in Running economy under the tested conditions.
  • Population: athletes.
  • Protocol cues (title/abstract): 24 h • 72 h • 3000 m • 12 km.

Protocol

Protocol (as reported)

  • Intervention/exposure: photobiomodulation, therapy (vs placebo).
  • Dose/time/duration cues in abstract/title: 24 h • 72 h • 3000 m • 12 km.
  • Outcomes: Running economy.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it may help, and who should be cautious

Who it helps

  • Athletes similar to the study population (athletes) working on biomechanics.
  • Athletes who can measure Running economy with a repeatable workout or time-trial effort.

Who should be cautious

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: randomized trial (placebo-controlled).
  • Population: athletes.
  • Comparator: placebo.
  • Outcomes measured: Running economy.
  • Protocol cues mentioned: 24 h • 72 h • 3000 m • 12 km.
  • Source: PubMed PMID 33459175 (2021) — Journal of sports sciences.

Results excerpt

What the abstract reports

Athletes performed the 3000 m running test ~7s faster when treated with PBMT with similar effort score compared placebo condition.

Note: excerpts are short; for full context, read the paper.

Limits

Limitations and bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Adaptive AI coach for iPhone

Meet your adaptive AI coach.

Tell your coach what you are training for. It builds the plan, follows the work you complete, and adapts upcoming training when recovery, your schedule, or real life changes.

Keep going

Sources